BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

538 hedge funds and large institutions have $14.7B invested in BioMarin Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 191 increasing their positions, 192 reducing their positions, and 70 closing their positions.

Holders
538
Holders Change
-18
Holders Change %
-3.24%
% of All Funds
9.1%
Holding in Top 10
12
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+100%
% of All Funds
0.2%
New
65
Increased
191
Reduced
192
Closed
70
Calls
$85.1M
Puts
$94.2M
Net Calls
-$9.1M
Net Calls Change
-$54.5M

Top Buyers

1
Barclays
1
Barclays
United Kingdom
$179M
2
Viking Global Investors
2
Viking Global Investors
Connecticut
$419M
3
SIG
3
Senator Investment Group
New York
$70.4M
4
1832 Asset Management
4
1832 Asset Management
Ontario, Canada
$99.6M
5
DTC
5
Deep Track Capital
Connecticut
$54.2M

Top Sellers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$409M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$43.5M
3
ClearBridge Investments
3
ClearBridge Investments
New York
$93.2M
4
Citadel Advisors
4
Citadel Advisors
Florida
$95.6M
5
MNG
5
Manning & Napier Group
New York
$78.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
Legal & General Group
26
Legal & General Group
United Kingdom
$104M +$5.53M +66,683 +6%
FWIA
27
Fort Washington Investment Advisors
Ohio
$102M +$87K +1,050 +0.1%
Deutsche Bank
28
Deutsche Bank
Germany
$102M +$27.8M +335,397 +38%
Charles Schwab
29
Charles Schwab
California
$99.6M +$6.14M +74,080 +7%
1832 Asset Management
30
1832 Asset Management
Ontario, Canada
$99.6M +$58.1M +701,500 +140%
Bank of America
31
Bank of America
North Carolina
$98.3M -$1.65M -19,926 -2%
Citadel Advisors
32
Citadel Advisors
Florida
$95.6M -$77.7M -937,328 -45%
ClearBridge Investments
33
ClearBridge Investments
New York
$93.2M -$81.6M -984,288 -47%
Rockefeller Capital Management
34
Rockefeller Capital Management
New York
$92.6M -$1.22M -14,734 -1%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$86.9M +$29.9M +360,411 +52%
Morgan Stanley
36
Morgan Stanley
New York
$86.5M +$32.4M +391,301 +60%
MNG
37
Manning & Napier Group
New York
$78.4M -$62.9M -758,954 -45%
SIG
38
Senator Investment Group
New York
$70.4M +$70.4M +850,000 New
PHS
39
PFM Health Sciences
California
$69.6M +$10M +120,876 +17%
Goldman Sachs
40
Goldman Sachs
New York
$68.2M +$9.45M +114,080 +16%
Swiss National Bank
41
Swiss National Bank
Switzerland
$66.2M +$257K +3,100 +0.4%
HM
42
HealthCor Management
New York
$61.4M -$2.33M -28,068 -4%
Renaissance Technologies
43
Renaissance Technologies
New York
$60.9M +$20.2M +243,592 +50%
Jennison Associates
44
Jennison Associates
New York
$60.4M +$1.88M +22,642 +3%
Victory Capital Management
45
Victory Capital Management
Texas
$59M -$124K -1,498 -0.2%
DTC
46
Deep Track Capital
Connecticut
$54.2M +$54.2M +654,365 New
Nuveen Asset Management
47
Nuveen Asset Management
Illinois
$53.3M -$2.56M -30,907 -5%
SI
48
Scout Investments
Missouri
$53.1M -$770K -9,289 -1%
Axa
49
Axa
France
$51.2M +$15.7M +189,380 +44%
FCM
50
Frontier Capital Management
Massachusetts
$50.6M +$16.9M +204,399 +50%
1
2
3 4 5